Keyphrases
Pharmacogenetics
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Hyperglycemia
100%
Disease Progression
100%
Response to Treatment
100%
Individual Response
100%
Genetic Risk Score
50%
Antidiabetic Treatment
50%
Treatment Progression
25%
Genotype
25%
Metabolizer
25%
Diabetes
25%
KCNJ11
25%
Inter-individual Variation
25%
Risk Score Model
25%
Type 2 Diabetic Patients
25%
CYP2C9
25%
Clinical Practice Guidelines
25%
Type 2 Diabetes Risk
25%
Treatment Standards
25%
Drug Receptor
25%
Inter-individual Responses
25%
Diagnostic Criteria
25%
Heritability
25%
Risk Variant
25%
Genetic Variants
25%
Complex Disease
25%
Response to Therapy
25%
Progressors
25%
Antidiabetic Drugs
25%
Patients with Diabetes
25%
Diagnostic Interventions
25%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Pharmacogenetics
100%
Hyperglycemia
100%
Disease Exacerbation
80%
Diseases
40%
Genetic Risk
40%
Heritability
20%
Drug Receptor
20%
Patient with Type 2 Diabetes
20%
Diabetes
20%
Optical Coherence Tomography
20%
Diagnosis
20%
Human Genetics
20%
Antidiabetic Agent
20%
Patient with Diabetes
20%
Biochemistry, Genetics and Molecular Biology
Pharmacogenetics
100%
Genetic Divergence
100%
Hyperglycemia
100%
Genetic Risk
100%
Genotyping
50%
CYP2C9
50%
ABCC8
50%
Human Genetics
50%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacogenetics
100%
Non Insulin Dependent Diabetes Mellitus
100%
Hyperglycemia
100%
Disease Exacerbation
66%
Diseases
33%
Genetic Risk
33%
Antidiabetic Agent
16%
Drug Receptor
16%
CYP2C9
16%